- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 38/46 - Hydrolases (3)
Détention brevets de la classe A61K 38/46
Brevets de cette classe: 3564
Historique des publications depuis 10 ans
|
217
|
230
|
282
|
285
|
313
|
311
|
375
|
395
|
315
|
75
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Regents of the University of California | 18943 |
154 |
| University of Vienna | 109 |
78 |
| Alexion Pharmaceuticals, Inc. | 606 |
62 |
| Emmanuelle Charpentier | 53 |
52 |
| President and Fellows of Harvard College | 5792 |
50 |
| Massachusetts Institute of Technology | 9795 |
44 |
| Takeda Pharmaceutical Company Limited | 2961 |
43 |
| The Broad Institute, Inc. | 1584 |
42 |
| Curemark, LLC | 78 |
42 |
| Sangamo Therapeutics, Inc. | 437 |
35 |
| Yale University | 2204 |
34 |
| ContraFect Corporation | 91 |
29 |
| The Trustees of Columbia University in the City of New York | 3440 |
26 |
| Duke University | 2872 |
26 |
| Regeneron Pharmaceuticals, Inc. | 3650 |
26 |
| Children's Medical Center Corporation | 1780 |
25 |
| Genzyme Corporation | 1205 |
24 |
| The Board of Trustees of the Leland Stanford Junior University | 6054 |
23 |
| Novozymes A/S | 3314 |
21 |
| Precision Biosciences, Inc. | 167 |
21 |
| Autres propriétaires | 2707 |